Amphastar Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $149.2M | $513.6M | $86.3M |
| FY2019 | $159.4M | $587.0M | $73.7M |
| FY2020 | $182.5M | $631.2M | $92.6M |
| FY2021 | $226.0M | $671.5M | $126.4M |
| FY2022 | $213.3M | $742.0M | $156.1M |